JAK inhibition shows two faces in prostate cancer

Nat Cancer. 2022 Sep;3(9):1021-1023. doi: 10.1038/s43018-022-00437-3.

Authors

Nicholas J Brady¹, Christopher E Barbieri^{2

3

4}

Affiliations

¹ Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
² Department of Urology, Weill Cornell Medicine, New York, NY, USA. chb9074@med.cornell.edu.
³ Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. chb9074@med.cornell.edu.
⁴ Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. chb9074@med.cornell.edu.

PMID: 36138136
DOI: 10.1038/s43018-022-00437-3

No abstract available

Publication types

Comment

MeSH terms

Humans
Janus Kinases
Male
Prostatic Neoplasms* / drug therapy

Substances

Janus Kinases